Effects of underwater ultrasound therapy on pain, inflammation, hand function and quality of life in patients with rheumatoid arthritis – a randomized controlled trial

Márta Király, Zsuzsanna Varga, Ferenc Szanyó, Rita Kiss, Katalin Hodosi, T. Bender

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives To investigate the effects of underwater ultrasound (US) therapy in 48 patients with moderately active rheumatoid arthritis (disease activity score in 28 joints [DAS28] > 3.2 and < 5.1). Methods Patients randomly assigned to the ultrasound group (n = 25) received underwater continuous ultrasound therapy to both wrists and hands for 7 min per session with an intensity of 0.7 W/cm2 for 10 sessions. The control group (n = 23) received sham treatment under the same conditions. At baseline, at the end of treatment (end of Week 2) and at the follow-up visit (Week 14), the following outcomes were evaluated: disease activity (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], tender and swollen joint counts, pain on a visual analog scale, DAS28, hand function (fist making, wrist extension and flexion, hand grip strength) and quality of life (Health Assessment Questionnaire [HAQ]). Results A significant decrease in C-reactive protein at the end of Week 2 and Week 14 compared to control group (mean between-group difference at 2 weeks = −5.77, 95% CI = −10.86 to −0.68, mean between-group difference at 14 weeks = −5.07, 95% CI = −10.13 to −0.01), and non-significant decrease in DAS28 was observed. By the end of treatments at the end of week 2, ultrasound alleviated pain significantly (mean between-group difference at two weeks = −8.35 95% CI = −16.12 to −0.58), as well as improved left wrist extension compared to the control group (mean between-group difference at 14 weeks = 4.35, 95% CI = 1.09–7.60). Conclusion Underwater ultrasound therapy was better than sham treatment at the end of 2 weeks of treatment, but not at long term (14 weeks) in patients with rheumatoid arthritis. Clinical trial registration number: NCT02706028 (https://clinicaltrials.gov/ct2/show/NCT02706028)

Original languageEnglish
Pages (from-to)199-205
Number of pages7
JournalBrazilian Journal of Physical Therapy
Volume21
Issue number3
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Rheumatoid Arthritis
Randomized Controlled Trials
Hand
Quality of Life
Inflammation
Pain
Wrist
Hand Strength
C-Reactive Protein
Control Groups
Therapeutics
Joints
Placebos
Hand Joints
Blood Sedimentation
Arthralgia
Visual Analog Scale
Clinical Trials
Health

Keywords

  • Physical therapy
  • Rheumatoid arthritis
  • Underwater ultrasound therapy

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Orthopedics and Sports Medicine
  • Rehabilitation

Cite this

Effects of underwater ultrasound therapy on pain, inflammation, hand function and quality of life in patients with rheumatoid arthritis – a randomized controlled trial. / Király, Márta; Varga, Zsuzsanna; Szanyó, Ferenc; Kiss, Rita; Hodosi, Katalin; Bender, T.

In: Brazilian Journal of Physical Therapy, Vol. 21, No. 3, 01.05.2017, p. 199-205.

Research output: Contribution to journalArticle

@article{dd780ac563344f969c3f424db7c5d1f1,
title = "Effects of underwater ultrasound therapy on pain, inflammation, hand function and quality of life in patients with rheumatoid arthritis – a randomized controlled trial",
abstract = "Objectives To investigate the effects of underwater ultrasound (US) therapy in 48 patients with moderately active rheumatoid arthritis (disease activity score in 28 joints [DAS28] > 3.2 and < 5.1). Methods Patients randomly assigned to the ultrasound group (n = 25) received underwater continuous ultrasound therapy to both wrists and hands for 7 min per session with an intensity of 0.7 W/cm2 for 10 sessions. The control group (n = 23) received sham treatment under the same conditions. At baseline, at the end of treatment (end of Week 2) and at the follow-up visit (Week 14), the following outcomes were evaluated: disease activity (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], tender and swollen joint counts, pain on a visual analog scale, DAS28, hand function (fist making, wrist extension and flexion, hand grip strength) and quality of life (Health Assessment Questionnaire [HAQ]). Results A significant decrease in C-reactive protein at the end of Week 2 and Week 14 compared to control group (mean between-group difference at 2 weeks = −5.77, 95{\%} CI = −10.86 to −0.68, mean between-group difference at 14 weeks = −5.07, 95{\%} CI = −10.13 to −0.01), and non-significant decrease in DAS28 was observed. By the end of treatments at the end of week 2, ultrasound alleviated pain significantly (mean between-group difference at two weeks = −8.35 95{\%} CI = −16.12 to −0.58), as well as improved left wrist extension compared to the control group (mean between-group difference at 14 weeks = 4.35, 95{\%} CI = 1.09–7.60). Conclusion Underwater ultrasound therapy was better than sham treatment at the end of 2 weeks of treatment, but not at long term (14 weeks) in patients with rheumatoid arthritis. Clinical trial registration number: NCT02706028 (https://clinicaltrials.gov/ct2/show/NCT02706028)",
keywords = "Physical therapy, Rheumatoid arthritis, Underwater ultrasound therapy",
author = "M{\'a}rta Kir{\'a}ly and Zsuzsanna Varga and Ferenc Szany{\'o} and Rita Kiss and Katalin Hodosi and T. Bender",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.bjpt.2017.04.002",
language = "English",
volume = "21",
pages = "199--205",
journal = "Brazilian Journal of Physical Therapy",
issn = "1413-3555",
publisher = "Revista Brasileira de Fisioterapia",
number = "3",

}

TY - JOUR

T1 - Effects of underwater ultrasound therapy on pain, inflammation, hand function and quality of life in patients with rheumatoid arthritis – a randomized controlled trial

AU - Király, Márta

AU - Varga, Zsuzsanna

AU - Szanyó, Ferenc

AU - Kiss, Rita

AU - Hodosi, Katalin

AU - Bender, T.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Objectives To investigate the effects of underwater ultrasound (US) therapy in 48 patients with moderately active rheumatoid arthritis (disease activity score in 28 joints [DAS28] > 3.2 and < 5.1). Methods Patients randomly assigned to the ultrasound group (n = 25) received underwater continuous ultrasound therapy to both wrists and hands for 7 min per session with an intensity of 0.7 W/cm2 for 10 sessions. The control group (n = 23) received sham treatment under the same conditions. At baseline, at the end of treatment (end of Week 2) and at the follow-up visit (Week 14), the following outcomes were evaluated: disease activity (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], tender and swollen joint counts, pain on a visual analog scale, DAS28, hand function (fist making, wrist extension and flexion, hand grip strength) and quality of life (Health Assessment Questionnaire [HAQ]). Results A significant decrease in C-reactive protein at the end of Week 2 and Week 14 compared to control group (mean between-group difference at 2 weeks = −5.77, 95% CI = −10.86 to −0.68, mean between-group difference at 14 weeks = −5.07, 95% CI = −10.13 to −0.01), and non-significant decrease in DAS28 was observed. By the end of treatments at the end of week 2, ultrasound alleviated pain significantly (mean between-group difference at two weeks = −8.35 95% CI = −16.12 to −0.58), as well as improved left wrist extension compared to the control group (mean between-group difference at 14 weeks = 4.35, 95% CI = 1.09–7.60). Conclusion Underwater ultrasound therapy was better than sham treatment at the end of 2 weeks of treatment, but not at long term (14 weeks) in patients with rheumatoid arthritis. Clinical trial registration number: NCT02706028 (https://clinicaltrials.gov/ct2/show/NCT02706028)

AB - Objectives To investigate the effects of underwater ultrasound (US) therapy in 48 patients with moderately active rheumatoid arthritis (disease activity score in 28 joints [DAS28] > 3.2 and < 5.1). Methods Patients randomly assigned to the ultrasound group (n = 25) received underwater continuous ultrasound therapy to both wrists and hands for 7 min per session with an intensity of 0.7 W/cm2 for 10 sessions. The control group (n = 23) received sham treatment under the same conditions. At baseline, at the end of treatment (end of Week 2) and at the follow-up visit (Week 14), the following outcomes were evaluated: disease activity (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], tender and swollen joint counts, pain on a visual analog scale, DAS28, hand function (fist making, wrist extension and flexion, hand grip strength) and quality of life (Health Assessment Questionnaire [HAQ]). Results A significant decrease in C-reactive protein at the end of Week 2 and Week 14 compared to control group (mean between-group difference at 2 weeks = −5.77, 95% CI = −10.86 to −0.68, mean between-group difference at 14 weeks = −5.07, 95% CI = −10.13 to −0.01), and non-significant decrease in DAS28 was observed. By the end of treatments at the end of week 2, ultrasound alleviated pain significantly (mean between-group difference at two weeks = −8.35 95% CI = −16.12 to −0.58), as well as improved left wrist extension compared to the control group (mean between-group difference at 14 weeks = 4.35, 95% CI = 1.09–7.60). Conclusion Underwater ultrasound therapy was better than sham treatment at the end of 2 weeks of treatment, but not at long term (14 weeks) in patients with rheumatoid arthritis. Clinical trial registration number: NCT02706028 (https://clinicaltrials.gov/ct2/show/NCT02706028)

KW - Physical therapy

KW - Rheumatoid arthritis

KW - Underwater ultrasound therapy

UR - http://www.scopus.com/inward/record.url?scp=85030840170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030840170&partnerID=8YFLogxK

U2 - 10.1016/j.bjpt.2017.04.002

DO - 10.1016/j.bjpt.2017.04.002

M3 - Article

C2 - 28442212

AN - SCOPUS:85030840170

VL - 21

SP - 199

EP - 205

JO - Brazilian Journal of Physical Therapy

JF - Brazilian Journal of Physical Therapy

SN - 1413-3555

IS - 3

ER -